October 30, 2014 News by Isaura Santos Multiple Sclerosis, Autoimmune Disease Diagnoses, Treatments To Improve Using New DNA Software Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently developed a software tool that helps researchers understand the complex genetic origins of many autoimmune diseases and, ultimately, to better diagnose and treat them. The study was published yesterday inĀ …
October 24, 2014 News by Patricia Silva, PhD MS Society Canada Urges Parliamentarians to Improve MS Clinics While Canada is home to one of the world’s most comprehensive social healthcare systems, it is unfortunately home to one of the largestĀ multiple sclerosisĀ patient populations as well. According to the Multiple Sclerosis Society of Canada, at least 100,000 Canadians have the disease, and at least 20,000 of them live…
October 20, 2014 News by Patricia Silva, PhD MS Blueprint Online Program by Biogen Helps Patients Live Happier Cambridge, Massachusetts-basedĀ Biogen IdecĀ has just announced a new support program for people living with multiple sclerosis (MS) that encourages patients to turn their attention to daily activities that enhance their emotional and mental state. The newly launched MS Blueprint program assists patients and caregivers in setting positive and realistic goals,…
October 17, 2014 News by Isaura Santos “MS Radio” Offers Multiple Sclerosis Patients Breaking News, Articles & Tips About the Disease Multiple Sclerosis information resourceĀ MSology.com has announced the launch ofĀ MS Radio, an exclusive MS-focused radio program, to celebrate the organization’s second anniversary. MSology.com provides news, feature articles and practical tips to more than 100,000 people worldwide. The first radio episode (available here) is a…
October 15, 2014 News by Patricia Silva, PhD Urinary Prosthesis Better than Catheterization for Female MS Patients One of the concerns patients with neurologic diseases such as multiple sclerosisĀ face is decline or loss of bladder control. It can be an embarrassing and frustrating problem, which is estimated to occur in about 80% of MS patients, as the disease causes a slowing down or interruption in signal transmission…
October 14, 2014 News by Patricia Silva, PhD Ankar Pharma Opens Crowdfunding for Promising MS Drug Spanish-Filipino biopharmaceutical startupĀ Ankar PharmaĀ is working on a promising treatment for multiple sclerosis (MS). Dr. Ana Martinez, a professor and researcher at theĀ Biological Research Center (CIB) of the Spanish National Council for Research (CSIC), explains that while there are several palliative treatments available on the market…
October 7, 2014 News by Patricia Silva, PhD Oklahoma Medical Research Foundation Receives Multiple Sclerosis Innovation Grant A scientist from the Oklahoma Medical Research Foundation (OMRF) is the recipient of 1 of only 5 Multiple Sclerosis Innovation grants from German biopharmaceutical company EMD Serono. Manu Nair, the foundation’s Vice President of Technology Ventures, said that this funding from a new collaborative relationship is a crucial step towards…
October 3, 2014 News by Patricia Silva, PhD National MS Society Pledges $19 Million Dollars to Fund 54 New Studies 54 new multiple sclerosis (MS)Ā research and development initiatives are set to receive substantial funding in order to accelerate new therapies. The National Multiple Sclerosis Society (NMSS) announced that it has pledged $19 million to fund these new MS studies as part of their mission to better manage…
September 30, 2014 News by Patricia Silva, PhD Multiple Sclerosis Self-Management Scale Enhances Patient Independence Multiple sclerosis (MS) is a chronic, autoimmune neurodegenerative disease that the biomedical research and pharmaceutical industry has yet to find a cure for. It is a progressively debilitating condition that manifests with a number of unpredictable symptoms that can greatly reduce one’s quality of life. In order…
September 29, 2014 News by Patricia Silva, PhD MS Patients Can Tolerate Exercise According to University of Vermont Study A new study conducted at theĀ Department of Rehabilitation and Movement Science of the University of Vermont, reinforces the idea that multiple sclerosis patients can handleĀ exerciseĀ regimens, despite their mobility difficulties, in order toĀ improve not only their motor capacities, but also their quality of life. Although over 90% of…
September 29, 2014 News by Patricia Silva, PhD Kessler Study Recommends Wellness Program for Multiple Sclerosis In today’s healthcare environment, it is often not enough that patients are provided with the latest treatments. Good health is not merely the absence of injury or disease, but overall wellness that includes mental, spiritual and social health. A group of investigators from the Kessler Foundation…
September 25, 2014 News by Patricia Silva, PhD Evotec Multiple Sclerosis Drug Studies Receive ā¬5 Million in New Funding Funding for continued research and development into understanding, treating, and eventually curing Multiple Sclerosis continues to accelerate. Evotec AG, aĀ German company that specializes in providing drug discovery resources to pharmaceutical and biotech companies, and learning institutions, has just announced the launch of its line-up of groundbreaking studies intoĀ MSĀ — an…
September 22, 2014 News by Patricia Silva, PhD Women with Disabilities Like Multiple Sclerosis Photographed for The Raw Beauty Project NYC Joy Nabors – The Raw Beauty Project NYC model living with Multiple Sclerosis In a bold movement aimed towards empowering disabled women to stand against social stigmas, the Christopher & Dana Reeve Foundation partnered with innovative visual arts project, Raw Beauty Project NYC, to showcase a series of photographs…
September 11, 2014 News by Patricia Silva, PhD MS Diagnosis Inspires Miss Kentucky For 2015 Miss America Pageant For a 23 year-old country girl from the University of Kentucky to go through the harsh demands of an American beauty pageant, there has to be an inspiration stemming from something more profound than a desire for world peace, a sash, and a shiny crown. Last month, on July 12th,…
September 10, 2014 News by Patricia Silva, PhD Largest Multiple Sclerosis Conference Begins in Boston; 8,000 Attendees Expected See below for the complete schedule for this year’sĀ ACTRIMS-ECTRIMS Multiple Sclerosis conference in Boston, and stay tuned to Multiple Sclerosis News throughout the week for continuing coverage on breaking science and research news for MS. For the past few weeks, Multiple Sclerosis News Today has been following the lead-up…
September 9, 2014 News by Patricia Silva, PhD Large Multiple Sclerosis Product Update To Be Presented By Biogen Biogen Idec, one of the first true biotech companies specializing in products indicated forĀ neurodegenerative diseases, hematologic conditions, and autoimmune disorders, is preparing to present over 90 poster presentations during this week’s 6th Joint ACTRIMS-ECTRIMS Meeting. The event is scheduled to take place from Wednesday, September 10th through Saturday the…
September 5, 2014 News by Patricia Silva, PhD Future MS Therapies Could Target, Treat Intestinal Barrier A new study, entitled, āIntestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cellsā conducted at University of Lund, Sweden, published on PlosOneĀ by the research group of Dr. Shahram Lavasani in collaboration with…
September 3, 2014 News by Patricia Silva, PhD Researchers Advance New Stem Cell Methods for Remyelination in MS Patients In-vitro laboratory experiments using stem cells have long-since been the subject of debate between scientists and naturalists, but when it comes to developing effective methods to grow human cells and tissue for use in a potentially life-saving procedure or restoration of bodily function, researchers are increasingly more confident that…
September 1, 2014 News by Patricia Silva, PhD New Multiple Sclerosis Drug May Repair Nerve Demyelination As researchers continue to develop a clearer understanding of the underlying causes ofĀ multiple sclerosis (MS), it is becoming increasingly apparent that the future of treating the disease is likely to center on neural protection and a reversal of the demyelination process that strips away the critical insulation…
August 20, 2014 News by admin New Relapsing-Remitting Multiple Sclerosis Drug Approved By FDA Biogen Idec, a biotechnology company focused on developing innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders, has announced that the U.S. Food and Drug Administration (FDA) has approved PLEGRIDYTMĀ (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis…
August 6, 2014 News by admin HIV Infection May Suppress Development of MS, According To Study According to a study published in theĀ Journal of Neurology Neurosurgery & Psychiatry, HIV infection is correlated to a significantly lower risk of developing multiple sclerosis (MS). The researchers analyzed a previous report by a team of Danish researchers whereby an HIV positive man with MS had his symptoms…